A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients. Serina Therapeutics, based ...
Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...
Bangkok Post on MSN
New treatment improves care for Parkinson's disease patients
Chiang Mai Neurological Hospital has reported success in treating patients with Parkinson's disease using apomorphine subcutaneous injections, particularly in cases where patients show intermittent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results